This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.
Study Type
OBSERVATIONAL
Enrollment
223
Hospital Sant Joan Despi Moises Broggi; Servicio de Neurología
Sant Joan Despí, Barcelona, Spain
Percentage of Participants with Serious Adverse Events (Severe Life-Threatening or Less Severe)
Time frame: Up to 3 months
Percentage of Participants With DMT Administration Schedule Preferences
Time frame: Up to 3 months
Percentage of Participants With DMT Route of Administration Preferences
Time frame: Up to 3 months
DMT Efficacy Based on Annualized Relapse Rate
Time frame: Up to 3 months
Participants Education Level
Time frame: Baseline
Participants Employment Status
Time frame: Baseline
Participants RRMS Disease Duration
Time frame: Baseline
Number of Relapses of RRMS in Last 2 Years
Time frame: Baseline
Duration since Last Relapse of RRMS
Time frame: Baseline
Participants Current DMT for RRMS
Time frame: Baseline
Number of Previous DMTs Taken Prior to Switch to Current DMT
Time frame: Baseline
Expanded Disability Status Scale (EDSS) Score
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Universitario Marques de Valdecilla; Servicio de Neurología
Santander, Cantabria, Spain
Hospital General de Castellon; Servicio de Neurología
Castellon, Castellon, Spain
Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Neurología
Lleida, Lerida, Spain
Hospital Universitario del Sureste; Servicio de Neurologia
Arganda, Madrid, Spain
Hospital Universitario Rey Juan Carlos de Móstoles; Servicio de Neurología
Móstoles, Madrid, Spain
Hospital Quiron de Madrid; Servicio de Neurologia
Pozuelo de Alarcón, Madrid, Spain
Complejo Hospitalario Universitario de Vigo - Xeral Cies; Servicio de Neurologia
Vigo, Pontevedra, Spain
Hospital Universitario de Canarias; Servicio de Neurologia
San Cristóbal de La Laguna, Tenerife, Spain
Hospital del Mar; Servicio de Neurologia
Barcelona, Spain
...and 8 more locations
Time frame: Up to 3 months
Health-Related Quality of Life Assessment Using Euro-Quality of Life 5 Dimension Questionnaire (EQ-5D) Scale Score
Time frame: Up to 3 months
Participant's Role in Decision Making measured by the Shared Decision Making Questionnaire 9-item version (SDM-Q-9) Score
Time frame: Up to 3 months
Cognitive performance as measured by the Medical Outcomes Study Cognitive Functioning Scale (MOS Cog-R) Score
Time frame: Up to 3 months